PUBLIC CONTRACT · 2023
Aquisição de medicamentos analgésicos, antipiréticos e antidepressivos revogados no âmbito do procedimento 51/44/2023 e outros (CPA 2021/44)
- Contract value
- €1,587.50
- Signed on
- 23 February 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9829751PUBLISHED DESCRIPTION
51/75/2023
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Guarda, Guarda
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GENERIS · Tax ID 508107997
- Bidder
- LABORATÓRIO MEDINFAR - PRODUTOS FARMACÊUTICOS, S.A. · Tax ID 500384045
- Bidder
- MYLAN LDA · Tax ID 502248793
- Bidder
- Overpharma, Produtos Médicos e Farmacêuticos, Lda · Tax ID 505792362
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €1,587.50
- Procedure base price
- €2,186.03
- Total effective price
- Not reported on Portal BASE
- Publication date
- 1 March 2023
- Award date
- 23 February 2023
- Signing date
- 23 February 2023
- Performance period
- 330 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/44 - Medicamentos analgésicos, antipiréticos e antidepressivos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6299316
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.